Mesa (Pharmaceutical Development) Overview

  • Founded
  • 2011
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Mesa (Pharmaceutical Development) General Information


Provider of pharmaceutical development services intended to focus on drug delivery development, clinical study design and operation. The company's services include formulation services, pre-clinical services, clinical services, regulatory services and drug development services, enabling their clients to plan and execute their pharmaceutical development process.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 4539 Metropolitan Court
  • Suite 207
  • Frederick, MD 21701
  • United States
+1 (301) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mesa (Pharmaceutical Development) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view Mesa (Pharmaceutical Development)’s complete valuation and funding history, request access »

Mesa (Pharmaceutical Development) Executive Team (2)

Name Title Board Seat Contact Info
Kenneth Dretchen Ph.D Vice President & Chief Scientific Officer
Michael Mesa Founder & President
To view Mesa (Pharmaceutical Development)’s complete executive team members history, request access »

Mesa (Pharmaceutical Development) Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Frederick Innovative Technology Center Accelerator/Incubator Minority 000 0000 000000 0
To view Mesa (Pharmaceutical Development)’s complete investors history, request access »